Free Trial
NASDAQ:ACET

Adicet Bio (ACET) Stock Price, News & Analysis

Adicet Bio logo
$0.77 0.00 (-0.54%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$0.77 0.00 (-0.32%)
As of 07/25/2025 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Adicet Bio Stock (NASDAQ:ACET)

Key Stats

Today's Range
$0.76
$0.78
50-Day Range
$0.61
$0.82
52-Week Range
$0.45
$1.70
Volume
122,175 shs
Average Volume
380,294 shs
Market Capitalization
$63.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Moderate Buy

Company Overview

Adicet Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

ACET MarketRank™: 

Adicet Bio scored higher than 56% of companies evaluated by MarketBeat, and ranked 475th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Adicet Bio has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Adicet Bio has only been the subject of 1 research reports in the past 90 days.

  • Read more about Adicet Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Adicet Bio are expected to decrease in the coming year, from ($1.39) to ($1.73) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Adicet Bio is -0.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Adicet Bio is -0.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Adicet Bio has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Adicet Bio's valuation and earnings.
  • Percentage of Shares Shorted

    4.35% of the float of Adicet Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Adicet Bio has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Adicet Bio has recently increased by 14.88%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Adicet Bio does not currently pay a dividend.

  • Dividend Growth

    Adicet Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.35% of the float of Adicet Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Adicet Bio has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Adicet Bio has recently increased by 14.88%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Adicet Bio has a news sentiment score of 1.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.06 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 12 news articles for Adicet Bio this week, compared to 2 articles on an average week.
  • Search Interest

    15 people have searched for ACET on MarketBeat in the last 30 days. This is an increase of 1,400% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Adicet Bio to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Adicet Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.80% of the stock of Adicet Bio is held by insiders.

  • Percentage Held by Institutions

    83.89% of the stock of Adicet Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Adicet Bio's insider trading history.
Receive ACET Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adicet Bio and its competitors with MarketBeat's FREE daily newsletter.

ACET Stock News Headlines

Adicet Bio, Inc. (ACET) Balance Sheet - Yahoo Finance
Elon Musk: “This will transform civilization as we know it.”
Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by 2025, robots will shift from novelty to necessity — disrupting nearly every industry in their path. But one overlooked sector could become the real winner… and one little-known company may be the best way to get ahead of the boom.
Adicet Bio, Inc. (ACET) Balance Sheet - Yahoo Finance
See More Headlines

ACET Stock Analysis - Frequently Asked Questions

Adicet Bio's stock was trading at $0.9620 at the beginning of the year. Since then, ACET shares have decreased by 19.8% and is now trading at $0.7715.

Adicet Bio, Inc. (NASDAQ:ACET) announced its earnings results on Tuesday, May, 6th. The company reported ($0.31) EPS for the quarter, topping the consensus estimate of ($0.34) by $0.03.

Adicet Bio's top institutional shareholders include Vontobel Holding Ltd. (0.10%). Insiders that own company stock include Orbimed Advisors Llc, Don Healey, Chen Schor, Blake Aftab and Steve Dubin.
View institutional ownership trends
.

Shares of ACET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Adicet Bio investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Walmart (WMT).

Company Calendar

Last Earnings
5/06/2025
Today
7/25/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Trading Companies & Distributors
Current Symbol
NASDAQ:ACET
CIK
2034
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$4.00
Potential Upside/Downside
+677.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.30)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$117.12 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-59.05%
Return on Assets
-50.66%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.34
Quick Ratio
9.34

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.26 per share
Price / Book
0.34

Miscellaneous

Outstanding Shares
82,710,000
Free Float
76,259,000
Market Cap
$63.81 million
Optionable
Optionable
Beta
1.62

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:ACET) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners